Latest Insider Transactions at Aethlon Medical Inc (AEMD)
This section provides a real-time view of insider transactions for Aethlon Medical Inc (AEMD). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of AETHLON MEDICAL INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of AETHLON MEDICAL INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2025
|
Chetan Shah Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,786
-8.2%
|
$1,786
$1.2 P/Share
|
|
Jun 30
2025
|
Nicolas Gikakis Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,786
-8.2%
|
$1,786
$1.2 P/Share
|
|
Jun 30
2025
|
Edward G Broenniman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
893
-3.93%
|
$893
$1.2 P/Share
|
|
Apr 23
2025
|
Chetan Shah Director |
SELL
Grant, award, or other acquisition
|
Direct |
142,857
-45.05%
|
$0
$0.36 P/Share
|
|
Apr 23
2025
|
Edward G Broenniman Director |
BUY
Grant, award, or other acquisition
|
Direct |
142,857
+44.01%
|
$0
$0.35 P/Share
|
|
Apr 23
2025
|
Angela Rossetti Director |
BUY
Grant, award, or other acquisition
|
Direct |
142,857
+29.38%
|
$0
$0.35 P/Share
|
|
Apr 23
2025
|
Nicolas Gikakis Director |
BUY
Grant, award, or other acquisition
|
Direct |
142,857
+45.04%
|
$0
$0.35 P/Share
|
|
Mar 31
2025
|
Nicolas Gikakis Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,289
-9.46%
|
$0
$0.36 P/Share
|
|
Mar 31
2025
|
Chetan Shah Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,289
-9.49%
|
$0
$0.36 P/Share
|
|
Mar 31
2025
|
Edward G Broenniman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,645
-4.06%
|
$0
$0.36 P/Share
|
|
Dec 31
2024
|
Nicolas Gikakis Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,289
-8.65%
|
$0
$0.86 P/Share
|
|
Dec 31
2024
|
Chetan Shah Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,289
-8.67%
|
$0
$0.86 P/Share
|
|
Dec 31
2024
|
Edward G Broenniman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,645
-3.9%
|
$0
$0.86 P/Share
|
|
Sep 30
2024
|
Chetan Shah Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,289
-7.97%
|
$0
$0.47 P/Share
|
|
Sep 30
2024
|
Edward G Broenniman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,645
-3.75%
|
$0
$0.47 P/Share
|
|
Sep 30
2024
|
Nicolas Gikakis Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,289
-7.96%
|
$0
$0.47 P/Share
|
|
Jun 28
2024
|
Edward G Broenniman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,645
-3.62%
|
$0
$0.5 P/Share
|
|
Jun 28
2024
|
Nicolas Gikakis Director |
SELL
Payment of exercise price or tax liability
|
Direct |
5,244
-11.26%
|
$0
$0.5 P/Share
|
|
Jun 28
2024
|
Chetan Shah Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,289
-7.39%
|
$0
$0.5 P/Share
|
|
Apr 16
2024
|
Edward G Broenniman Director |
BUY
Grant, award, or other acquisition
|
Direct |
32,894
+41.98%
|
$32,894
$1.52 P/Share
|
|
Apr 16
2024
|
Nicolas Gikakis Director |
BUY
Grant, award, or other acquisition
|
Direct |
32,894
+41.39%
|
$32,894
$1.52 P/Share
|
|
Apr 16
2024
|
Chetan Shah Director |
BUY
Grant, award, or other acquisition
|
Direct |
32,894
+42.48%
|
$32,894
$1.52 P/Share
|
|
Apr 16
2024
|
Angela Rossetti Director |
BUY
Grant, award, or other acquisition
|
Direct |
32,894
+14.09%
|
$32,894
$1.52 P/Share
|
|
Mar 29
2024
|
Chetan Shah Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,163
-9.09%
|
$1,163
$1.68 P/Share
|
|
Mar 29
2024
|
Edward G Broenniman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,163
-8.47%
|
$1,163
$1.68 P/Share
|
|
Mar 29
2024
|
Nicolas Gikakis Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,954
-12.5%
|
$1,954
$1.68 P/Share
|
|
Dec 29
2023
|
Edward G Broenniman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,163
-7.81%
|
$2,326
$2.19 P/Share
|
|
Dec 29
2023
|
Nicolas Gikakis Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,954
-11.11%
|
$3,908
$2.19 P/Share
|
|
Dec 29
2023
|
Chetan Shah Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,163
-8.33%
|
$2,326
$2.19 P/Share
|
|
Sep 29
2023
|
Nicolas Gikakis Director |
SELL
Payment of exercise price or tax liability
|
Direct |
19,541
-10.0%
|
$0
$0.23 P/Share
|
|
Sep 29
2023
|
Edward G Broenniman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
11,628
-7.24%
|
$0
$0.23 P/Share
|
|
Sep 29
2023
|
Chetan Shah Director |
SELL
Payment of exercise price or tax liability
|
Direct |
11,628
-7.69%
|
$0
$0.23 P/Share
|
|
Jul 03
2023
|
Nicolas Gikakis Director |
BUY
Grant, award, or other acquisition
|
Direct |
195,414
+50.0%
|
-
|
|
Jun 30
2023
|
Edward G Broenniman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
11,628
-6.75%
|
$0
$0.36 P/Share
|
|
Jun 30
2023
|
Chetan Shah Director |
SELL
Payment of exercise price or tax liability
|
Direct |
11,628
-7.14%
|
$0
$0.36 P/Share
|
|
Apr 28
2023
|
Chetan Shah Director |
BUY
Grant, award, or other acquisition
|
Direct |
116,279
+41.65%
|
-
|
|
Apr 28
2023
|
Angela Rossetti Director |
BUY
Grant, award, or other acquisition
|
Direct |
116,279
+40.95%
|
-
|
|
Apr 28
2023
|
Edward G Broenniman Director |
BUY
Grant, award, or other acquisition
|
Direct |
116,279
+40.31%
|
-
|
|
Mar 31
2023
|
Edward G Broenniman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,425
-5.77%
|
$0
$0.38 P/Share
|
|
Mar 31
2023
|
Chetan Shah Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,425
-6.84%
|
$0
$0.38 P/Share
|
|
Dec 30
2022
|
Edward G Broenniman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,425
-5.46%
|
$0
$0.28 P/Share
|
|
Dec 30
2022
|
Chetan Shah Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,425
-6.41%
|
$0
$0.28 P/Share
|
|
Sep 30
2022
|
Edward G Broenniman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
6,849
-9.84%
|
$0
$0.58 P/Share
|
|
Sep 30
2022
|
Chetan Shah Director |
SELL
Payment of exercise price or tax liability
|
Direct |
6,849
-11.36%
|
$0
$0.58 P/Share
|
|
Sep 15
2022
|
Angela Rossetti Director |
BUY
Grant, award, or other acquisition
|
Direct |
51,370
+50.0%
|
-
|
|
Sep 15
2022
|
Edward G Broenniman Director |
BUY
Grant, award, or other acquisition
|
Direct |
34,247
+32.97%
|
-
|
|
Sep 15
2022
|
Chetan Shah Director |
BUY
Grant, award, or other acquisition
|
Direct |
34,247
+36.22%
|
-
|
|
Mar 31
2022
|
Chetan Shah Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,430
-8.53%
|
$2,430
$1.46 P/Share
|
|
Mar 31
2022
|
Edward G Broenniman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,430
-6.43%
|
$2,430
$1.46 P/Share
|
|
Mar 31
2022
|
Sabrina Martucci Johnson Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,430
-6.74%
|
$2,430
$1.46 P/Share
|